How Genetic Background of Pregnant Women Can Influence NIPT Results
A specific genetic variant found in about 7% of Dutch women reduces the accuracy of NIPT, increasing the likelihood of inconclusive results.
Category: Prenatal Testing
Prenatal Testing
Latest
Prenatal Testing
Latest
DDC Launches Peekaboo Click Early Gender DNA Test
The Peekaboo Click test will enable expecting parents to discover their baby's gender very early in pregnancy from a simple blood sample, with results returned from the lab as soon as the same day.
Prenatal Testing
Latest
Sera Prognostics’ Data Shows Benefit of Preterm Birth Risk Assessment Tool
Sera Prognostics, a company focused on curbing preterm birth risks, demonstrated data on the health and economic benefits of its PreTRM test.
Portfolio of Reproductive Information-Driven Genomic Solutions Introduced
Sema4 Elements, a portfolio of information-driven genomic reproductive health solutions that enable providers to treat patients holistically, has launched.
Read More
Many Pregnant Women Don’t Get Blood Test to Check Iron Levels
Half of pregnant women who had a simple blood test to check their iron stores had low iron levels; one in four had severe iron deficiency.
Read More
BioReference Laboratories Acquires Prenatal Testing Business from Roche
BioReference Laboratories, Inc. has acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche.
Read More
EchelonDx, Cradle Genomics Join Forces on Non-Invasive Prenatal Diagnostic Products
As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Read More
Real-World Evidence Shows Cost Effectiveness of Offering NIPT to All Pregnant Women
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Read More
Scientists Develop Blood Test to Predict Environmental Harms to Children
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read More
Sera Prognostics PreTRM Blood Test Gets CPT PLA Code
The new CPT PLA code will facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention.
Read More
Sera Prognostics, Anthem Launch Study to Improve Outcomes for Preterm Babies
The PRIME study is designed to provide a blueprint for how healthcare can more effectively identify and manage high-risk pregnancies and reduce preterm birth.
Read More
Protein Linked to Gestational Diabetes
A new study outlines a role for pregnancy-associated plasma protein A in gestational diabetes, with potential as a diagnostic tool and therapeutic target.
Read More
Progenity Test for Triaging Preeclampsia Passes Key Development Milestone
This proprietary test is a multi-analyte protein biomarker assay which is designed to be run from a simple blood draw.
Read More
Study: Enhanced Common Blood Test Could Predict Adverse Outcomes in Pregnancy
A blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.
Read More
Myriad’s Amplify Technology Improves Prequel NIPS Test
The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.
Read More
Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read MoreBillionToOne Has Closed Its Follow-On Series A+ Funding Round of $15 Million
The new funding will be used to support commercial expansion of the company’s Unity prenatal screening test to all US states as well as research and development for future diagnostics.
Read More
Thermo Fisher Scientific and NX Prenatal Collaborate to Develop Fetal Health Assays
Thermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.
Read More